HEALTHY
Clinical trials for HEALTHY explained in plain language.
Never miss a new study
Get alerted when new HEALTHY trials appear
Sign up with your email to follow new studies for HEALTHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early drug trial for eczema halted after limited testing
Disease control TerminatedThis early-stage study aimed to test the safety of a new drug called LY3872386. It involved healthy volunteers and people with atopic dermatitis (eczema) to see how their bodies handled the drug. The study was terminated early, so no final results on effectiveness are available.
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Military tests silver gel in battle against hand germs
Prevention TerminatedThis study tested if a new hand gel containing tiny silver particles works better than a common alcohol-based gel at killing bacteria. Researchers applied both gels to the hands of healthy volunteers after putting a safe, traceable bacteria on their skin. They measured how well e…
Matched conditions: HEALTHY
Phase: PHASE3 • Sponsor: Madigan Army Medical Center • Aim: Prevention
Last updated Mar 03, 2026 14:06 UTC
-
Natural gel tested for Women's intimate health
Symptom relief TerminatedThis small pilot study tested a gel containing proteins from stem cells and licorice root extract to see if it could safely improve vaginal tightness (laxity). Eighteen women in Malaysia, aged 40-55, used the product for 5 weeks. Researchers measured changes in tightness and chec…
Matched conditions: HEALTHY
Phase: NA • Sponsor: USMARI Research & Innovation Centre • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Can meditation and breathing exercises help parole officers cope with stress?
Symptom relief TerminatedThis study tested a training program to help parole officers manage job stress and burnout. It taught staff meditation, breathing exercises, and other mind-body techniques to increase resilience and reduce anxiety. The program aimed to see if these skills improved officers' well-…
Matched conditions: HEALTHY
Phase: NA • Sponsor: The Center for Mind-Body Medicine • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC
-
First human tests for new pill halted after safety check
Knowledge-focused TerminatedThis was an early-stage study to check the safety and side effects of a new oral drug called LY3526318 in healthy people. It also measured how the drug moves through and is processed by the body. The study was terminated after enrolling 76 participants and did not aim to treat an…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
First human tests for new drug candidate halted early
Knowledge-focused TerminatedThis was an early-stage study to check the safety and see how the body processes a new drug called MT-6345. It involved 52 healthy volunteers who received either the drug or a placebo. The main goal was to see what side effects occurred and measure how the drug moved through and …
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Tanabe Pharma America, Inc. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test brain delivery of insulin via a simple nasal spray
Knowledge-focused TerminatedThis early-stage study aimed to find out if insulin, delivered as a nasal spray, can reach the brain and spinal fluid. Researchers gave a single dose to healthy young adults and collected spinal fluid samples to measure insulin levels over time. The goal was to gather basic evide…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: HealthPartners Institute • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Can your workout change how you feel pain?
Knowledge-focused TerminatedThis study aimed to find out if a 10-week exercise program could change how healthy, sedentary people process pain. Researchers compared moderate-intensity training to high-intensity training to see which was better at reducing pain sensitivity. The goal was to gather knowledge t…
Matched conditions: HEALTHY
Phase: NA • Sponsor: University Ghent • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Terminated trial sheds light on experimental Drug's journey through the body
Knowledge-focused TerminatedThis early-stage study aimed to understand how the body absorbs, processes, and eliminates an experimental drug called BI 1819479. It involved a small group of 7 healthy male volunteers and was terminated early. The research focused on measuring how much of the drug entered the b…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
First human tests: does a new Pill's formula change with food?
Knowledge-focused TerminatedThis early-stage study aimed to check the safety and see how the body processes a new drug called BI 3009947 in healthy men. It tested increasing single doses and compared two different pill versions to see if one worked better or if food changed how the drug was absorbed. The tr…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Scientists test new tasteless antibiotic powder
Knowledge-focused TerminatedThis early-stage study tested a new, taste-masked powder version of an antibiotic called delafloxacin, which is used to treat pneumonia. The goal was to see how much of the drug gets into the bloodstream from the new powder compared to the standard tablet. The study involved 16 h…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Melinta Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Scientists track new Drug's journey through the body
Knowledge-focused TerminatedThis early-stage study aims to understand how a new drug called BI 1839100 is absorbed, processed, and eliminated by the body. It involves a small group of healthy male volunteers. Researchers will track the drug's path by measuring how much appears in blood, urine, and feces aft…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists test malaria drug mix in healthy volunteers
Knowledge-focused TerminatedThis study aimed to understand how two common malaria drug combinations interact when taken together. It involved a small group of healthy adults who took the medications so researchers could measure drug levels in their blood and check for safety. The goal was to gather informat…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists track Body's flu shot response for six months
Knowledge-focused TerminatedThis early research study aimed to understand how the immune systems of healthy adults respond to two different seasonal flu vaccines. Two participants received both vaccines at the same time, one in each arm. Researchers collected blood and lymph node samples over six months to …
Matched conditions: HEALTHY
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Pfizer halts Early-Stage drug safety trial
Knowledge-focused TerminatedThis was an early-stage study to check the safety and see how the body processes an experimental oral drug called PF-07899895. It involved 37 healthy adult volunteers who received either the drug or a placebo dummy pill. The main goals were to see if the drug was safe and to meas…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists track how ashwagandha moves through the body
Knowledge-focused TerminatedThis small, early-stage study aimed to understand how the body absorbs and processes a specific ashwagandha supplement in healthy adults aged 65 and older. Researchers measured the levels of the supplement's active compounds in participants' blood and urine over time to learn how…
Matched conditions: HEALTHY
Phase: EARLY_PHASE1 • Sponsor: Oregon Health and Science University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Drug maker halts early safety test in healthy men
Knowledge-focused TerminatedThis early-stage study aimed to check the safety and see how the experimental drug BI 706321 moves through the bodies of healthy Japanese and Chinese men. The trial was terminated and did not test the drug for any specific disease. It involved 48 healthy male volunteers to gather…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Drug maker halts early safety test on new compound
Knowledge-focused TerminatedThis early-stage study aimed to check the safety and see how the body processes a new drug called BI 3731579. It involved 30 healthy adults who took the drug for 15 days. The main goal was to see what side effects occurred and to measure the drug's levels in the blood. The trial …
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Early drug test halted: safety check on new injection
Knowledge-focused TerminatedThis early-stage study aimed to check the safety and side effects of a new drug called LY3463251 when given as an injection under the skin. It involved 118 healthy and overweight volunteers to see how their bodies handled single and multiple doses. The main goal was to gather bas…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Why exercise might not help the heart in some lung disease patients
Knowledge-focused TerminatedThis study aimed to understand why exercise training, a key part of rehabilitation for COPD (chronic lung disease), might not improve blood vessel health as effectively in some patients. Researchers compared 69 people—some with COPD and some healthy—measuring blood vessel functio…
Matched conditions: HEALTHY
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Brain hormone tested as potential pain blocker
Knowledge-focused TerminatedThis study aimed to understand if the hormone oxytocin, given through an IV, could reduce pain. Researchers tested this by applying a mild, heated probe to the skin of healthy volunteers and people with severe knee arthritis, asking them to rate their pain. The goal was to create…
Matched conditions: HEALTHY
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC
-
First human tests for new Alzheimer's pill halted
Knowledge-focused TerminatedThis was an early-stage study to check the safety of a new oral medicine called REM0045392, which is being developed to treat Alzheimer's disease. It involved 19 healthy men and older adults who took single or multiple doses over 14 days. The main goal was to see how the body pro…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: reMYND • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists test inhaled gas to see inside lungs and brain with MRI
Knowledge-focused TerminatedThis study aims to test new MRI hardware and software that uses a safe, inhaled xenon gas to take pictures of the lungs and brain. Healthy adult volunteers will have scans to see if this method produces clear images. The goal is to gather knowledge to improve future imaging techn…
Matched conditions: HEALTHY
Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC
-
Pfizer halts early test of mystery medicine
Knowledge-focused TerminatedThis was an early-stage study by Pfizer to check the basic safety of a new, unnamed medicine called PF-07314470 and see how the body processes it. It involved a small group of healthy adults who received injections of the medicine or a placebo. The main goal was to identify any s…
Matched conditions: HEALTHY
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC